Sign in

CIK 0001636282 · Large accelerated filer

Spyre Therapeutics, Inc.

Sign in to watch
Ticker
SYRE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
464312787
Phone
6176515940
Business address
221 CRESCENT STREET, BUILDING 23, SUITE 105, WALTHAM, MA, 02453
Former names
Aeglea BioTherapeutics, Inc.
  1. 8-K Event Results of operations
  2. 8-K Event Material agreement
  3. 8-K Event Regulation FD disclosure · Other events
  4. 8-K Event Regulation FD disclosure · Other events
  5. 8-K Event Results of operations
  6. 8-K Event Regulation FD disclosure · Other events
  7. 8-K Event Other events
  8. 8-K Event Executive or director change · Shareholder vote results
  9. 8-K Event Results of operations
  10. 8-K Event Material agreement
  11. 8-K Event Results of operations · Other events
  12. 8-K Event Regulation FD disclosure · Other events
  13. 8-K Event Results of operations
  14. 8-K Event Regulation FD disclosure
  15. 8-K Event Results of operations · Regulation FD disclosure · Other events
  16. 8-K Event Material agreement
  17. 8-K Event Results of operations
  18. 8-K Event Results of operations
  19. 8-K Event Regulation FD disclosure · Other events
  20. 8-K Event Shareholder vote results

Page 1 of 9 · 173 filings